JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.

MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.

Neurosci Biobehav Rev December 22, 2010 DOI: 10.1016/j.neubiorev.2010.12.010 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract

Characteristics	Theoretical or philosophical paper Peer reviewed
Topics	MDMA Neuroplasticity
Key points	Argues that MDMA abuse exemplifies dopamine neuroplasticity, suggesting that dopamine-related neuroplastic changes contribute to the drug's addictive potential.

Abstract

MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity.

Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse Journal of Neurochemistry March 12, 2021 47 citations
MDMA ("ecstasy") and neurotoxicity. Science June 1, 2003 36 citations
Morphological adaptations in the brain motive circuit induced by 3,4‐methylenedioxymethamphetamine (MDMA; ecstasy) The FASEB Journal April 1, 2010
Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation Pharmaceuticals July 5, 2011 6 citations
Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation. Clinical toxicology (Philadelphia, Pa.) August 2010